![](/img/cover-not-exists.png)
Phase 2 Study of ABT-122, a TNF- and IL-17A-Targeted Dual Variable Domain Immunoglobulin, in Psoriatic Arthritis With Inadequate Methotrexate Response
Mease, Philip J., Genovese, Mark C., Weinblatt, Michael E., Peloso, Paul M., Chen, Kun, Othman, Ahmed A., Li, Yihan, Mansikka, Heikki T., Khatri, Amit, Wishart, Neil, Liu, JohnLanguage:
english
Journal:
Arthritis & Rheumatology
DOI:
10.1002/art.40579
Date:
May, 2018
File:
PDF, 997 KB
english, 2018